Guided Capital Wealth Management LLC Acquires New Stake in Encompass Health Corporation (NYSE:EHC)

Guided Capital Wealth Management LLC acquired a new stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 20,693 shares of the company's stock, valued at approximately $2,096,000. Encompass Health accounts for approximately 1.8% of Guided Capital Wealth Management LLC's investment portfolio, making the stock its 17th largest holding.

Other large investors have also bought and sold shares of the company. Colonial Trust Co SC bought a new position in Encompass Health in the 4th quarter worth approximately $29,000. Transce3nd LLC bought a new position in shares of Encompass Health in the fourth quarter worth $40,000. CBIZ Investment Advisory Services LLC grew its position in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after purchasing an additional 127 shares in the last quarter. Signaturefd LLC raised its stake in shares of Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after purchasing an additional 125 shares during the period. Finally, Johnson Financial Group Inc. bought a new stake in shares of Encompass Health during the 4th quarter valued at $72,000. 97.25% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently commented on EHC shares. Stephens upgraded shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price objective for the company in a research report on Thursday, June 5th. Royal Bank Of Canada raised their price target on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a report on Monday, April 28th. KeyCorp boosted their price target on shares of Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a research report on Tuesday, May 27th. UBS Group increased their price objective on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Finally, Wall Street Zen cut Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. Eight investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Encompass Health has a consensus rating of "Buy" and a consensus price target of $127.00.

Encompass Health Trading Up 0.6%

NYSE EHC traded up $0.68 during trading on Thursday, hitting $119.87. 526,464 shares of the company's stock traded hands, compared to its average volume of 703,029. The stock has a fifty day moving average of $115.12 and a two-hundred day moving average of $103.74. Encompass Health Corporation has a 12-month low of $82.74 and a 12-month high of $123.13. The firm has a market cap of $12.08 billion, a P/E ratio of 24.77, a PEG ratio of 2.42 and a beta of 0.89. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.06 and a quick ratio of 1.06.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, topping analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The business had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. During the same period in the previous year, the firm earned $1.12 EPS. The business's quarterly revenue was up 10.6% on a year-over-year basis. As a group, sell-side analysts expect that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a $0.17 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 annualized dividend and a yield of 0.57%. Encompass Health's dividend payout ratio (DPR) is presently 14.05%.

Insiders Place Their Bets

In related news, EVP John Patrick Darby sold 10,000 shares of the stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total value of $1,147,900.00. Following the completion of the transaction, the executive vice president now directly owns 79,710 shares in the company, valued at $9,149,910.90. This trade represents a 11.15% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Elissa Joy Charbonneau sold 4,279 shares of Encompass Health stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total transaction of $498,974.19. Following the transaction, the insider now directly owns 11,958 shares of the company's stock, valued at approximately $1,394,422.38. This trade represents a 26.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 132,663 shares of company stock worth $16,034,082 over the last three months. Company insiders own 2.00% of the company's stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.